We are live on
!
Find out more
LCM
Laurion Capital Management Portfolio holdings
AUM
$2.29B
1-Year Est. Return
75.73%
This Fund
S&P 500
This Quarter
Est. Return
+6.97%
1 Year Est. Return
+75.73%
3 Year Est. Return
+162.63%
5 Year Est. Return
+130.38%
10 Year Est. Return
+388.8%
AUM
$17.9B
AUM Growth
+$3.18B
(+22%)
Cap. Flow
+$2.11B
Cap. Flow
% of AUM
11.82%
Top 10 Holdings %
Top 10 Hldgs %
38.29%
Holding
721
New
293
Increased
98
Reduced
124
Closed
140
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$124M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$95.2M |
| 3 |
Pliant Therapeutics
PLRX
|
+$74.8M |
| 4 |
Microsoft
MSFT
|
+$72.6M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$56.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viatris
VTRS
|
+$123M |
| 2 |
CTLT
CATALENT, INC.
CTLT
|
+$60.4M |
| 3 |
Emerson Electric
EMR
|
+$55M |
| 4 |
Home Depot
HD
|
+$54.8M |
| 5 |
Comcast
CMCSA
|
+$53.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.44% |
| 2 | Technology | 2.51% |
| 3 | Communication Services | 1.69% |
| 4 | Utilities | 1.38% |
| 5 | Industrials | 0.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Caesarstone
CSTE
$79.5M
| $90.4K | ﹤0.01% |
+17,247
| New | +$78.1K |
|
|
MKFG
527
DELISTED
Markforged Holding Corporation
MKFG
| $86.7K | ﹤0.01% |
+7,169
| New | +$67.5K |
|
|
NUTX
528
Nutex Health
NUTX
$1.11B
| $86.6K | ﹤0.01% |
+1,369
| New | +$117K |
|
529
Telos
TLS
$358M
| $85.9K | ﹤0.01% |
+33,566
| New | +$79.6K |
|
530
Microvast
MVST
$302M
| $84.9K | ﹤0.01% |
+53,081
| New | +$75.7K |
|
531
Bionano Genomics
BNGO
$13.3M
| $84.8K | ﹤0.01% |
+232
| New | +$105K |
|
532
Salesforce
CRM
$158B
| $84.5K | ﹤0.01% |
+400
| New | +$81.7K |
|
533
Genworth Financial
GNW
$3.71B
| $83.5K | ﹤0.01% |
+16,692
| New | +$91.3K |
|
|
PVBC
534
DELISTED
Provident Bancorp
PVBC
| $83.2K | ﹤0.01% |
+10,054
| New | +$75.8K |
|
|
OPTU
535
Optimum Communications Inc
OPTU
$301M
| $81.6K | ﹤0.01% |
+27,027
| New | +$76.8K |
|
|
FREE
536
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $80.5K | ﹤0.01% |
+20,034
| New | +$55.8K |
|
537
United Rentals
URI
$72.4B
| $79.7K | ﹤0.01% |
+179
| New | +$66.3K |
|
|
GOEV
538
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $79.6K | ﹤0.01% |
+361
| New | +$103K |
|
539
The Honest Company
HNST
$586M
| $74.6K | ﹤0.01% |
+44,423
| New | +$75.7K |
|
|
TELL
540
DELISTED
Tellurian Inc.
TELL
| $74.4K | ﹤0.01% |
+52,732
| New | +$70.9K |
|
|
AHT
541
Ashford Hospitality Trust
AHT
$21M
| $73.2K | ﹤0.01% |
+1,964
| New | +$73.8K |
|
542
Fate Therapeutics
FATE
$326M
| $73.2K | ﹤0.01% |
+15,386
| New | +$84.9K |
|
543
Dow Inc
DOW
$21.2B
| $73.1K | ﹤0.01% |
1,373
-626,590
| -100% | -$33.3M |
|
544
C4 Therapeutics
CCCC
$412M
| $71.5K | ﹤0.01% |
+25,983
| New | +$83.5K |
|
545
Porch Group
PRCH
$1.8B
| $71.4K | ﹤0.01% |
+51,728
| New | +$62.7K |
|
546
Ouster
OUST
$2.92B
| $68.9K | ﹤0.01% |
+13,955
| New | +$72.9K |
|
|
GTHX
547
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $66.4K | ﹤0.01% |
26,655
| – | – |
|
|
SOND
548
DELISTED
Sonder
SOND
| $66K | ﹤0.01% |
+6,220
| New | +$67.4K |
|
549
Erasca
ERAS
$6.39B
| $63.8K | ﹤0.01% |
23,100
| – | – |
|
550
PUT
Truist Financial
TFC
$64B
| $63.7K | ﹤0.01% |
+2,100
| New | +$65.2K |
|
Similar funds
AFM
GCP
LCM
MAP
MA
LFM
NSAM
ABI
Laurion Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Laurion Capital Management held 721 positions worth $17.9B, up 22% from $14.7B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Laurion Capital Management deployed $2.11B of net new capital in Q2 2023, opening 293 new positions and adding to 98 existing holdings. Its largest new stake was Pliant Therapeutics: 3,158,570 shares worth $57.2M.
By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, down from 6.6% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Viatris, an estimated $123M trimmed.
- Laurion Capital Management's largest Q2 2023 buy was Pliant Therapeutics: 3,158,570 shares worth $57.2M.
- Laurion Capital Management added most to T-Mobile US in Q2 2023, an estimated $124M increase.
- Laurion Capital Management's biggest Q2 2023 reduction was Viatris, cutting an estimated $123M.
- Laurion Capital Management fully exited CATALENT, INC. in Q2 2023, selling an estimated $60.4M.
- Laurion Capital Management's ten largest holdings make up 38% of its $17.9B portfolio in Q2 2023.
- Laurion Capital Management opened 293 new positions and closed 140 in Q2 2023.
- Laurion Capital Management's portfolio value rose 22% quarter-over-quarter to $17.9B.
Based on Laurion Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.